ÂÜÀòÂÒÂ×

Keren Leshem serves as the Chief Executive Officer and Board Director at OCON Therapeutics since September 2019, previously holding the position of Vice President Sales & Business Development. In addition, Keren Leshem is involved with several organizations, including Aspivix and RAMBAM MedTech as a Director on their Board of Directors, and has been recognized as a Tech Pioneer 2022 by the World Economic Forum. Keren Leshem also contributes as a Mentor at 8400 - The Health Network, an Advisory Board Member for LSX Femtech Leaders, and a member of the board of admissions for FemTech Lab, while participating in the HealthTech CEO Forum organized by McKinsey & Company. Previous experience includes an Entrepreneur In Residence role at the Singapore National Eye Centre and a board membership at ViSci. Keren Leshem holds an MBA from Clark University and a BA from New England College.